Cardiovascular Diseases The Cost-effectiveness of a uniform versus age-dependent Cut-off for Cardiovascular Disease Prevention Screening

被引：0
|
作者：
不详
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2023年 / 28卷 / 01期
关键词：
D O I：
10.1055/a-1983-8868
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF AN ADJUSTED POLYGENIC RISK SCORE IN CARDIOVASCULAR DISEASE PREVENTION
    Hatziandreou, E.
    Panagiotou, N.
    VALUE IN HEALTH, 2023, 26 (12) : S81 - S81
  • [42] The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective
    Zomer, Ella
    Liew, Danny
    Tonkin, Andrew
    Trauer, James M.
    Ademi, Zanfina
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 285 : 1 - 5
  • [43] The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study
    Marshall, Tom
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (04): : 523 - 528
  • [44] CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS - A COST-EFFECTIVENESS ANALYSIS
    Nolte, J. E. H.
    Neumann, T.
    Neumann, A.
    Manne, J.
    Mostardt, S.
    Abbara, S.
    Brady, T. J.
    Hoffmann, U.
    Gazelle, G. S.
    Wasem, J.
    Goehler, A.
    VALUE IN HEALTH, 2011, 14 (03) : A8 - A8
  • [45] COST-EFFECTIVENESS OF A HYPOTHETICAL SCREENING PROGRAM FOR LUNG CANCER AND CARDIOVASCULAR DISEASE IN CHINA
    Velikanova, R.
    Roux, M.
    Oudkerk, M.
    Postma, M.
    VALUE IN HEALTH, 2019, 22 : S875 - S875
  • [46] Offering a lifestyle intervention to women of premenopausal age as primary prevention for cardiovascular disease? - assessing its cost-effectiveness
    Gao, Lan
    Moodie, Marj
    INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 2022, 19 (01)
  • [47] Offering a lifestyle intervention to women of premenopausal age as primary prevention for cardiovascular disease? – assessing its cost-effectiveness
    Lan Gao
    Marj Moodie
    International Journal of Behavioral Nutrition and Physical Activity, 19
  • [48] CARDIOVASCULAR GENETIC RISK TESTING FOR TARGETING STATIN THERAPY IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: A COST-EFFECTIVENESS ANALYSIS
    Jarmul, Jamie A.
    Pletcher, Mark J.
    Earnshaw, Stephanie
    Weinberger, Morris
    Jonas, Daniel
    Avery, Christy
    Lich, Kristen Hassmiller
    Wheeler, Stephanie
    Pignone, Michael
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S133 - S134
  • [49] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [50] Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa
    Gaziano, T. A.
    HEART, 2008, 94 (02) : 140 - 144
12345